What could your Johnson & Johnson investment become?

Is Johnson & Johnson a dividend stock?

Yes — Johnson & Johnson (JNJ) pays a dividend yield of 3%, paid quarterly. It pays out about 50% of its earnings as dividends — a balance between rewarding shareholders and reinvesting in the business. Johnson & Johnson is also a dividend aristocrat — a company with a long track record of raising its dividend year after year.

Johnson & Johnson pays dividends quarterly, so investors receive income quarterly.

What sector is Johnson & Johnson in?

Johnson & Johnson (JNJ) is part of the Healthcare sector. Healthcare covers pharmaceuticals, medical devices, and health services. Demand tends to hold up across economic cycles because people need care in good times and bad. Johnson & Johnson trades at a price-to-earnings (P/E) ratio of around 16, which reflects how much investors are currently willing to pay for each dollar of the company's earnings.

💡 From band-aids to medicines. Has paid dividends for over 60 years straight.

⚡ Aristocrat — has raised its dividend for decades in a row.

How is this projection calculated?

The calculator above assumes a 6% average annual return — roughly in line with long-term stock-market averages — and compounds your investment year by year. Dividend income is estimated from Johnson & Johnson's current 3% yield. These are educational projections based on historical averages. Actual returns may vary, and your capital is at risk.